Spain Blood-based Biomaker For Sports Medicine Market Size & Outlook
Spain blood-based biomaker for sports medicine market, 2018-2030 (US$M)
Related Markets
Spain blood-based biomaker for sports medicine market highlights
- The Spain blood-based biomaker for sports medicine market generated a revenue of USD 14.2 million in 2023 and is expected to reach USD 19.3 million by 2030.
- The Spain market is expected to grow at a CAGR of 4.5% from 2024 to 2030.
- In terms of segment, ck was the largest revenue generating type in 2023.
- CRP is the most lucrative type segment registering the fastest growth during the forecast period.
Blood-based biomaker for sports medicine market data book summary
| Market revenue in 2023 | USD 14.2 million |
| Market revenue in 2030 | USD 19.3 million |
| Growth rate | 4.5% (CAGR from 2023 to 2030) |
| Largest segment | Ck |
| Fastest growing segment | CRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6 |
Other key industry trends
- In terms of revenue, Spain accounted for 2.1% of the global blood-based biomaker for sports medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany blood-based biomaker for sports medicine market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 86.6 million by 2030.
Ck was the largest segment with a revenue share of 18.31% in 2023. Horizon Databook has segmented the Spain blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.
The market in Spain is experiencing significant growth, driven by the increasing focus on athlete health and the rising incidence of sports-related injuries. Blood-based biomarkers have emerged as a crucial tool in this field, offering insights into injury risk, recovery, and overall athletic performance.
These biomarkers can help in the early detection of injuries and monitoring of recovery, enabling more personalized & effective treatment plans. A report published by the NIH in July 2022 highlighted a study involving Spanish athletes, which found that 101 players suffered 146 time-loss injuries.
This equated to an overall injury rate of 3.1 injuries per 1,000 hours, with a training injury rate of 1.8 injuries per 1,000 hours and a match injury rate of 11.2 injuries per 1,000 hours. The probability of a player sustaining an injury during the season was 34%, emphasizing the necessity for more effective injury prevention strategies.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood-based Biomaker for Sports Medicine Market Scope
Blood-based Biomaker for Sports Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Spain blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)
Spain Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
